Revvity and Profluent Join Forces to Advance AI-Enhanced Base Editing with Pin-point™ Platform

Combination of Revvity’s proprietary Pin-point platform and Profluent’s AI-engineered proteins created to inspire accelerated development o...

September 23, 2025 | Tuesday | News
Esperion and Otsuka Secure MHLW Approval for NEXLETOL® in Japan to Treat Hypercholesterolemia

Esperion announced that Otsuka Pharmaceutical Co., Ltd. (Otsuka), the Company’s partner for the development and commercialization of NEXLETOL® ...

September 22, 2025 | Monday | News
Alvotech and Fuji Pharma Secure Japanese Approval for Three New Biosimilars: Denosumab, Golimumab, and Aflibercept

Alvotech a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced th...

September 22, 2025 | Monday | News
Sunflower Therapeutics and SK bioscience Achieve First Milestone in Development of Cost-Effective 10-Valent HPV Vaccine

 Sunflower Therapeutics (Sunflower), a public benefit corporation transforming global access to protein manufacturing capacity for diverse applic...

September 19, 2025 | Friday | News
Ono Pharmaceutical and Deciphera Secure European Commission Approval for Vimseltinib (ROMVIMZA™) as First Therapy for TGCT in the EU

Vimseltinib is the first and only therapy with marketing authorization for the treatment of TGCT in the European Union Ono Pharmaceutical Co.,...

September 18, 2025 | Thursday | News
Crown Bioscience Expands US Footprint with New State-of-the-Art Model Development Center in Kannapolis, North Carolina

Crown Bioscience, a global contract research organization (CRO) headquartered in the United States and part of JSR Life Sciences and Japan-based JSR Corp...

September 18, 2025 | Thursday | News
AccuStem Sciences and EmeritusDX Expand Blood-Based Cancer Testing Capabilities with Advanced miRNA Platform

AccuStem Sciences, Inc. (OTCQB: ACUT), a clinical stage diagnostics company dedicated to improving outcomes for patients with or at risk of cancer, annou...

September 18, 2025 | Thursday | News
VintaBio Files Patents for Breakthrough Biotherapeutics Manufacturing Platform That Slashes Development Timelines

Proprietary process reduces development timelines from 18 months to as little as 3, eliminates reliance on traditional plastic flatware, and offers rap...

September 17, 2025 | Wednesday | News
NurExone’s U.S. Subsidiary Exo-Top Plans First Commercial Exosome Production Facility in Indianapolis

  NurExone Biologic Inc., a biopharmaceutical innovator in exosome-based regenerative therapies, is pleased to announce that its U.S. subsidiary, Exo...

September 17, 2025 | Wednesday | News
Monte Rosa Therapeutics and Novartis Expand Collaboration with New $120M Upfront Deal to Develop Novel Immunology Degraders

Novartis receives an exclusive license to an undisclosed discovery target Novartis also receives options to license two programs from Monte Rosa’s...

September 16, 2025 | Tuesday | News
Abzena Expands AbZelectPRO™ Platform with Next-Generation GS Knockout CHO Cell Lines for Enhanced Biologics Development

Abzena, the leading end-to-end integrated CDMO for complex biologics and bioconjugates, announced the expansion of its AbZelectPRO™ cell line deve...

September 16, 2025 | Tuesday | News
Thermo Fisher Scientific Launches Olink® Target 48 Neurodegeneration Panel for Absolute Quantification of Key Biomarkers

Targeted proteomics panel delivers absolute quantification of key and emerging biomarkers in one scalable assay Thermo Fisher Scientific Inc., the world...

September 16, 2025 | Tuesday | News
Beckman Coulter Life Sciences Launches Industry-First IR820 and IR870 Infrared Dye Antibody Conjugates for Flow Cytometry

Beckman Coulter Life Sciences, a Danaher company and a global leader in laboratory automation and innovation, announces the launch of its new IR820 and I...

September 16, 2025 | Tuesday | News
Gene Solutions Secures Patent for Platform Technology Targeting Mitochondrial Dysfunction in Neurological Diseases

Gene Solutions, a leader in mitochondrial dysfunction genomics and CNS drug discovery, announces the publication of its platform technology patent. The a...

September 12, 2025 | Friday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2025 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close